Vaginal Microbiome
The microbiome plays a crucial role in human reproduction. Evidence shows a direct correlation between its composition and reproductive success rates.
An imbalance in the vaginal microbiome may be related to implantation failures, unexplained infertility, or recurrent infections.
Regulating this balance is a highly valuable preventive and therapeutic strategy..
What does the vaginal microbiome test analyse?
- The distribution of microorganisms in the vagina, cervix, and uterus.
- The suitability of the reproductive microbiome for facilitating implantation and pregnancy development.
- The presence of pathogenic microorganisms that increase the risk of sexually transmitted infections or other infections affecting fertility.
- The proportion of beneficial microorganisms and their impact on the reproductive mucosa.
- Metabolic markers and vaginal pH.
Test Procedure
Sample collection
Vaginal swab sample collected from the transformation zone and the posterior fornix by clinical personnel.
Preservation
Place immediately into a ThinPrep™ container with preservative to ensure sample integrity
Logistics
Store refrigerated at 4 °C (for a minimum of 4 hours up to a maximum of 10 days) until arrival at the Pronacera laboratory.
Analysis
Identification and precise quantification of microorganisms via real-time quantitative PCR (qPCR).
Who is it aimed at?
Vaginal microbiome analysis is highly beneficial for women with:
Abnormal vaginal discharge or pelvic pain.
Vaginal burning or irritation.
Candidiasis or cystitis.
Recurrent vaginal infections.
Unexplained infertility.
Recurrent implantation failure or pregnancy loss.
Endometriosis, endometritis, adenomyosis.
Disorders associated with autoimmunity.
Obesity (as a contributing factor).
Repeated failure in egg donation treatments.
Personalised therapeutic recommendations tailored to each patient's results